Genetics and epigenetics of CLL.

Area of Science:

• Hematology
• Genomics
• Epigenetics

Background:

• Chronic lymphocytic leukemia (CLL) displays heterogeneous clinical behavior.
• Disease progression is linked to genetic factors like chromosomal abnormalities, immunoglobulin heavy chain variable region (IGHV) somatic hypermutation (SHM) status, and specific gene mutations.

Approach:

• This review summarizes recent advancements in understanding CLL biology.
• Utilizes next-generation sequencing (NGS) to explore the genomic and epigenomic landscape of CLL.

Key Points:

• Novel genetic and epigenetic alterations in CLL are being identified.
• These alterations significantly influence disease progression and clinical outcomes.
• Understanding these changes is crucial for predicting treatment response.

Conclusions:

• Recent discoveries in CLL genetics and epigenetics offer insights into disease heterogeneity.
• These findings are vital for developing personalized treatment strategies and improving patient care.